Company intelligence / Profile preview

Omni Bioceutical Innovations

Scottsdale, Arizona, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Omni Bioceutical Innovations' skin and hair recovery serums, including TAC Restorative lines, show effective reduction in post-procedure downtime, enhanced skin regeneration, and stimulated hair follicle health, supported by confocal microscopy and clinical case evidence; no major product complaints reported since launch.

Therapeutic areas: ImmunologyOtherDermatology
Modalities: BiologicGrowth factor protein therapyPeptidesRecombinant proteinCytokine
Industry: Biotech

Partnerships

Kane Biotech (coactiv+™ scalp care worldwide license agreement)

Beyond the preview

Go deeper on Omni Bioceutical Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omni Bioceutical Innovations.

Explore the full profile